Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kevin Buchi

Premium

Benitec Biopharma has appointed Kevin Buchi to its board of directors.

Buchi previously served as CEO of Cephalon prior to its acquisition by Teva Pharmaceutical in 2011. He currently sits on the boards of Stemline Therapeutics, Forward Pharma, and Alexza Pharamceuticals.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.